What is the recommended dosing of Valtrex (valacyclovir) for the treatment of Bell's palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Valacyclovir Dosing for Bell's Palsy

For Bell's palsy, valacyclovir should be dosed at 1,000 mg three times daily for 7 days, always in combination with oral corticosteroids and initiated within 72 hours of symptom onset. 1, 2

Treatment Recommendations

First-line Treatment

  • Oral corticosteroids are the primary treatment for Bell's palsy with strong evidence supporting their use 3, 4
  • Prednisone regimen: 50-60 mg daily for 5 days followed by a 5-day taper 1

Antiviral Therapy

  • Valacyclovir should never be used as monotherapy for Bell's palsy (strong recommendation against) 3
  • Valacyclovir may be offered as an adjunct to oral steroids within 72 hours of symptom onset 3
  • Dosing: 1,000 mg three times daily for 7 days 1, 2
  • Alternative: Acyclovir 400 mg five times daily for 10 days 1

Evidence Analysis

The American Academy of Otolaryngology-Head and Neck Surgery guidelines clearly state that antiviral monotherapy should not be prescribed for Bell's palsy 3. However, they do indicate that combination therapy with an oral antiviral plus steroids may be offered within 72 hours of symptom onset 3.

A 2023 rapid evidence review in American Family Physician confirms that valacyclovir (1 g three times daily for 7 days) combined with corticosteroids may reduce rates of synkinesis (involuntary co-contraction of facial muscles) 1.

The strongest evidence supporting combination therapy comes from a multicenter, randomized, placebo-controlled study by Hato et al. (2007), which found that valacyclovir plus prednisolone resulted in significantly better recovery rates (96.5%) compared to prednisolone alone (89.7%) 2. This benefit was particularly pronounced in patients with complete or severe palsy.

Important Clinical Considerations

  • Timing is critical: Treatment should be initiated within 72 hours of symptom onset 3
  • Patient selection: The benefit of combination therapy may be greatest in patients with severe facial paralysis 2
  • Contraindications: Consider patient-specific factors such as diabetes, pregnancy, or previous steroid intolerance 3
  • Monitoring: Patients should be reevaluated if they develop new or worsening neurologic findings or have incomplete recovery after 3 months 4

Common Pitfalls to Avoid

  1. Using antiviral therapy alone - This is ineffective and not recommended 3, 1
  2. Delaying treatment - Benefits diminish when treatment is initiated after 72 hours 3
  3. Neglecting eye protection - Patients with incomplete eye closure require measures to prevent corneal damage 4
  4. Overlooking severe cases - Patients with complete paralysis may benefit most from combination therapy 2

While some studies show modest or no additional benefit from adding valacyclovir to steroid therapy 5, 6, the most recent evidence and guidelines support the option of combination therapy, particularly for patients with severe palsy.

References

Research

Bell Palsy: Rapid Evidence Review.

American family physician, 2023

Research

Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Facial Nerve Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The course of pain in Bell's palsy: treatment with prednisolone and valacyclovir.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2009

Research

Bell's palsy - the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.